Application 218139

Type
NDA
Sponsor
NOVITIUM PHARMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TEZRULYTERAZOSIN HYDROCHLORIDESOLUTION;ORALEQ 1MG BASE/MLYesNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
82445ORIG 2025-06-03
79252ORIG 2024-07-30
79251ORIG 2024-07-30